Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2025-12-19 00:00:00 ET · period of report 2025-12-17 · accession 0001106578-25-000042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-12-19 | 2025-12-17+ | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $120.26 | +10.0K | 4,130 | New | +$1.20M |
| DMT | 2025-12-19 | 2025-12-17+ | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | S - Sale+OE | $505.38 | -10.0K | 130 | -99% | -$5.05M |
| DMT | 2025-12-19 | 2025-12-17+ | UTHR | ROTHBLATT MARTINE A | COB, CEO, Dir | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-17 | M | A | 4,000 | $120.26 | 4,130 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-19 | S | D | 500 | $505.45 | 1,630 | D | — | — | |
| 3 | Common | Common Stock | 2025-12-19 | M | A | 2,000 | $120.26 | 2,130 | D | — | — | |
| 4 | Common | Common Stock | 2025-12-18 | S | D | 1,500 | $510.86 | 130 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $510.445 to $511.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2025-12-18 | S | D | 500 | $509.42 | 1,630 | D | — | — | |
| 6 | Common | Common Stock | 2025-12-18 | S | D | 2,000 | $507.24 | 2,130 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $507.00 to $507.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2025-12-19 | S | D | 1,500 | $507.61 | 130 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $507.58 to $507.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Common Stock | 2025-12-17 | S | D | 1,500 | $500.52 | 2,630 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $500.12 to $500.725. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 9 | Common | Common Stock | 2025-12-17 | S | D | 2,500 | $501.35 | 130 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $501.13 to $501.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 10 | Common | Common Stock | 2025-12-18 | M | A | 4,000 | $120.26 | 4,130 | D | — | — | |
| 11 | Derivative | Stock Option | 2025-12-18 | M | D | 4,000 | $0.00 | 2,000 | D | $120.26 · 2020-03-15 to 2026-03-15 | 4,000 Common Stock | |
| 12 | Derivative | Stock Option | 2025-12-17 | M | D | 4,000 | $0.00 | 6,000 | D | $120.26 · 2020-03-15 to 2026-03-15 | 4,000 Common Stock | |
| 13 | Derivative | Stock Option | 2025-12-19 | M | D | 2,000 | $0.00 | 0 | D | $120.26 · 2020-03-15 to 2026-03-15 | 2,000 Common Stock |